Cho H, Choi B, Shin Y, Suh S, Park S. Neuroinflammation-Modulating Agent SB1617 Enhances LC3-Associated Phagocytosis to Mitigate Tau Pathology. ACS Chem Neurosci. 2023;14:4139-4152 pubmed publisher

Bhagat R, Minaya M, Renganathan A, Mehra M, Marsh J, Martinez R, et al. Long non-coding RNA SNHG8 drives stress granule formation in tauopathies. medRxiv. 2023;: pubmed publisher

Hill S, Esquivel A, Ospina S, Rahal L, Dickey C, Blair L. Chaperoning activity of the cyclophilin family prevents tau aggregation. Protein Sci. 2022;31:e4448 pubmed publisher

Kim K, Park S, Hong J, Koh J, Cho D, Hwang J, et al. Zinc enhances autophagic flux and lysosomal function through transcription factor EB activation and V-ATPase assembly. Front Cell Neurosci. 2022;16:895750 pubmed publisher

Iyaswamy A, Wang X, Krishnamoorthi S, Kaliamoorthy V, Sreenivasmurthy S, Kumar Durairajan S, et al. Theranostic F-SLOH mitigates Alzheimer's disease pathology involving TFEB and ameliorates cognitive functions in Alzheimer's disease models. Redox Biol. 2022;51:102280 pubmed publisher

Torres Garcia L, P Domingues J, Brandi E, Haikal C, Mudannayake J, Brás I, et al. Monitoring the interactions between alpha-synuclein and Tau in vitro and in vivo using bimolecular fluorescence complementation. Sci Rep. 2022;12:2987 pubmed publisher

Yuste Checa P, Trinkaus V, Riera Tur I, Imamoglu R, Schaller T, Wang H, et al. The extracellular chaperone Clusterin enhances Tau aggregate seeding in a cellular model. Nat Commun. 2021;12:4863 pubmed publisher

Park L, Hochrainer K, Hattori Y, Ahn S, Anfray A, Wang G, et al. Tau induces PSD95-neuronal NOS uncoupling and neurovascular dysfunction independent of neurodegeneration. Nat Neurosci. 2020;23:1079-1089 pubmed publisher

Iyaswamy A, Krishnamoorthi S, Song J, Yang C, Kaliyamoorthy V, Zhang H, et al. NeuroDefend, a novel Chinese medicine, attenuates amyloid-β and tau pathology in experimental Alzheimer's disease models. J Food Drug Anal. 2020;28:132-146 pubmed publisher

Song J, Malampati S, Zeng Y, Durairajan S, Yang C, Tong B, et al. A small molecule transcription factor EB activator ameliorates beta-amyloid precursor protein and Tau pathology in Alzheimer's disease models. Aging Cell. 2019;:e13069 pubmed publisher

Huang J, Huang F, Yang C. Moscatilin Ameliorates Tau Phosphorylation and Cognitive Deficits in Alzheimer's Disease Models. J Nat Prod. 2019;82:1979-1988 pubmed publisher

Lee H, Fan S, Huang F, Chao H, Hsu K, Lin T, et al. 5-Aroylindoles Act as Selective Histone Deacetylase 6 Inhibitors Ameliorating Alzheimer's Disease Phenotypes. J Med Chem. 2018;61:7087-7102 pubmed publisher

Fan S, Huang F, Liou J, Yang C. The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model. Cell Death Dis. 2018;9:655 pubmed publisher

Hassiotis S, Manavis J, Blumbergs P, Hattersley K, Carosi J, Kamei M, et al. Lysosomal LAMP1 immunoreactivity exists in both diffuse and neuritic amyloid plaques in the human hippocampus. Eur J Neurosci. 2018;47:1043-1053 pubmed publisher

Brunello C, Yan X, Huttunen H. Internalized Tau sensitizes cells to stress by promoting formation and stability of stress granules. Sci Rep. 2016;6:30498 pubmed publisher

Hoover B, Reed M, Su J, Penrod R, Kotilinek L, Grant M, et al. Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron. 2010;68:1067-81 pubmed publisher